• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[从可怕的流行病到罕见疾病——1750年至1900年瑞典的天花]

[From dreaded epidemic to rare disease - smallpox in Sweden 1750-1900].

作者信息

Sköld P

出版信息

Nord Medicinhist Arsb. 1994:87-108.

PMID:11640370
Abstract

Smallpox contributed to the death of 300,000 people in Sweden between 1750 and 1800. It was one of the most feared diseases of the time. Most victims were children under the age of 10 years. It is estimated that one out of every ten children died from smallpox. The mortality rate was between 10% and 20% but those who survived faced severe complications. Most common were the disfiguring pockmarks among those previously infected. It turned out that women who had contracted smallpox married much later in life than the healthy. Also, both female and male fertility was lowered by smallpox infection. By the mid 1750s inoculation was introduced in Sweden. This was a preventive method where a mild infection was given by putting smallpox matter into an incision in the skin. Success was restricted to the wealthy, even if the doctors tried to reach the common people. The main reasons were lack of confidence for doctors, medical and epidemiological risks, costs and an ineffective organization. In 1801 Eberhard Zacharias Munch of Rosenschöld performed the first vaccination with cowpox matter in Sweden. In a few years an extensive practise was stabilized, which made the Swedish population one of the best vaccinated in the world. Moreover, a unique registration was compiled which, together with the parish records, makes the country one of the best documented. The main reasons behind the success was previous experiences of inoculation, international influences, abolition of the physicians monopoly, an effective organization, better opportunities for financing and rewards, and the compulsory law of 1816.

摘要

1750年至1800年间,天花导致瑞典30万人死亡。它是当时最令人恐惧的疾病之一。大多数受害者是10岁以下的儿童。据估计,每十名儿童中就有一名死于天花。死亡率在10%至20%之间,但幸存者面临严重并发症。最常见的是先前感染者脸上留下的毁容痘疤。事实证明,感染天花的女性结婚年龄比健康女性晚得多。此外,天花感染还会降低男性和女性的生育能力。到18世纪50年代中期,瑞典引入了接种法。这是一种预防方法,通过将天花物质放入皮肤切口来引发轻度感染。即使医生试图推广到普通民众,但成功仅限于富人。主要原因是对医生缺乏信任、存在医学和流行病学风险、成本高以及组织不力。1801年,罗斯恩舍尔德的埃伯哈德·扎卡里亚斯·蒙克在瑞典首次用牛痘物质进行了接种。几年内,广泛的接种实践得以稳定,这使瑞典人口成为世界上接种率最高的人群之一。此外,还编制了一份独特的记录,与教区记录一起,使该国成为记录最完善的国家之一。成功背后的主要原因是先前的接种经验、国际影响、医生垄断的废除、有效的组织、更好的融资和奖励机会以及1816年的强制法。

相似文献

1
[From dreaded epidemic to rare disease - smallpox in Sweden 1750-1900].[从可怕的流行病到罕见疾病——1750年至1900年瑞典的天花]
Nord Medicinhist Arsb. 1994:87-108.
2
From inoculation to vaccination: smallpox in Sweden in the eighteenth and nineteenth centuries.从接种到疫苗接种:18世纪和19世纪瑞典的天花
Popul Stud (Camb). 1996 Jul;50(2):247-62. doi: 10.1080/0032472031000149336.
3
The key to success: the role of local government in the organization of smallpox vaccination in Sweden.成功的关键:瑞典地方政府在天花疫苗接种组织中的作用
Med Hist. 2000 Apr;44(2):201-26.
4
The history of smallpox.天花的历史。
Clin Dermatol. 2006 May-Jun;24(3):152-7. doi: 10.1016/j.clindermatol.2005.11.009.
5
[The last case of smallpox in Denmark--the organizing conditions in 1970].[丹麦天花最后一例——1970年的组织情况]
Dan Medicinhist Arbog. 2005;33:115-44.
6
[A comparative study on Inoculation in China and Japan].[中国与日本接种情况的比较研究]
Nihon Ishigaku Zasshi. 2004 Jun;50(2):187-222.
7
[Inoculation in Boston from 1721 to American Independence].[1721年至美国独立战争期间在波士顿的接种情况]
Nihon Ishigaku Zasshi. 1999 Mar;45(1):31-44.
8
[Infectious diseases and medical institutions in the late Chosen dynasty].[朝鲜王朝后期的传染病与医疗机构]
Uisahak. 1995;4(2):165-73.
9
[Not Available].[无可用内容]
Quellen Stud Gesch Pharm. 1997;73:1-284.
10
[The origin of vaccination: smallpox between science and history].[疫苗接种的起源:科学与历史之间的天花]
Ann Ig. 2002 Jan-Feb;14(1 Suppl 1):159-68.

引用本文的文献

1
The mark of success: The role of vaccine-induced skin scar formation for BCG and smallpox vaccine-associated clinical benefits.成功的标志:疫苗诱导的皮肤瘢痕形成在卡介苗和天花疫苗相关临床获益中的作用。
Semin Immunopathol. 2024 Aug 26;46(5):13. doi: 10.1007/s00281-024-01022-9.